Generex Biotechnology (GNBT) Seeing Upside After Positive Article on New Vaccine Technology
Tweet Send to a Friend
Shares of small cap company, Generex Biotechnology (Nasdaq: GNBT), are trading up over 12% this morning after announcing Antigen Express ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


